LONDON, UNITED KINGDOM and BOSTON, MASSACHUSETTS--(Marketwire - February 21, 2008) - Imaginatik plc (AIM: IMTK), a leading provider of innovation and collaborative problem-solving software and processes, is pleased to announce today that Pfizer Inc (“Pfizer”), the global pharmaceutical company and a customer of Imaginatik, has agreed to subscribe up to GBP500,000 for new ordinary shares of 0.0625p each in the Company (the “Subscription Shares”) (the “Subscription”). The funding will be used to expand Imaginatik’s enterprise social networking and collaboration technology to further improve the Company’s offering in this sector.
